Earlier this week, SRF leaders joined clinicians and scientists from around the world at the American College of Rheumatology’s (ACR) Convergence conference in Orlando, FL, one of the leading international gatherings focused on rheumatic diseases.
Beyond the conference sessions, the SRF convened two meetings, which brought together more than 50 members of the CONQUER Registry community, including principal investigators (PIs) and Research Coordinators (RCs) from 20 participating medical centers across the country.
These meetings helped align research priorities, strengthen collaboration, and ensure consistent, high-quality data collection across CONQUER’s participating sites. That work is already making a difference: CONQUER data are being used by leading pharmaceutical companies to inform the development of new treatments for scleroderma.
By bringing this community together and making valuable patient data available to researchers and industry partners, the SRF is helping accelerate scientific discovery and the development of better treatments for scleroderma, while bringing greater visibility about this disease to a global stage.
Pictured: CONQUER Research Coordinators